Ardent Health Inc. is facing a securities fraud class action lawsuit in the U.S. District Court for the Middle District of Tennessee. The lawsuit alleges that the company and certain senior executives violated federal securities laws, following a significant drop in Ardent Health’s stock price. The decline occurred after the company disclosed a $43 million decrease in quarterly revenue due to hindsight evaluations of historical collection trends and a $54 million increase in professional liability reserves related to adverse prior period claim developments from 2019 to 2022. Investors who purchased Ardent Health securities have until March 9, 2026, to seek appointment as lead plaintiff in the case.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ardent Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9654079) on February 13, 2026, and is solely responsible for the information contained therein.